|
The U.S.
Food and Drug Administration has approved a total replacement
joint for patients suffering from arthritis of the middle
joint in the finger, the proximal interphalangeal joint.
The Ascension®PIP
PyroCarbon Total Joint -- a two-part, bi-condylar, semi-constrained
prosthesis -- will expand limited treatment options presently
available, providing a durable, wear-resistant joint with
interchangeable parts.
"This
(approval) will allow us to provide another solution to hand
surgeons dealing with patients with debilitating arthritis,"
said Tim Seese, President and CEO of Ascension.
Ascension's
Ascension® MCP was the first total joint finger implant
of its kind to receive FDA approval.
Source:
Medical Week staff,
week of April 7, 2002
|
HOME PAGE
